HB Wealth Management LLC Has $364,000 Holdings in Waters Corporation $WAT

HB Wealth Management LLC lowered its stake in Waters Corporation (NYSE:WAT) by 6.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,044 shares of the medical instruments supplier’s stock after selling 71 shares during the period. HB Wealth Management LLC’s holdings in Waters were worth $364,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Olde Wealth Management LLC acquired a new position in shares of Waters during the 1st quarter worth about $25,000. Zions Bancorporation National Association UT acquired a new position in shares of Waters during the 1st quarter worth about $28,000. IFP Advisors Inc lifted its position in shares of Waters by 118.9% during the 1st quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock worth $30,000 after purchasing an additional 44 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in shares of Waters during the 1st quarter worth about $41,000. Finally, Steph & Co. acquired a new position in shares of Waters during the 2nd quarter worth about $73,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Waters in a research report on Saturday, September 27th. UBS Group reissued a “neutral” rating on shares of Waters in a research report on Tuesday, July 15th. Bank of America boosted their price objective on Waters from $370.00 to $375.00 and gave the stock a “neutral” rating in a research report on Thursday, June 26th. Robert W. Baird cut their price objective on Waters from $374.00 to $352.00 and set an “outperform” rating for the company in a research report on Wednesday, July 16th. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price target on Waters and gave the company a “hold” rating in a report on Tuesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $380.43.

Waters Trading Down 0.0%

Waters stock opened at $328.29 on Tuesday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56. The stock has a market cap of $19.54 billion, a price-to-earnings ratio of 29.60, a price-to-earnings-growth ratio of 3.06 and a beta of 1.04. The business has a 50 day moving average price of $297.43 and a two-hundred day moving average price of $324.75. The company has a quick ratio of 1.22, a current ratio of 1.75 and a debt-to-equity ratio of 0.55.

Waters (NYSE:WAT) last released its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.93 by $0.02. Waters had a return on equity of 38.60% and a net margin of 21.71%.The company had revenue of $771.33 million for the quarter, compared to analyst estimates of $745.96 million. During the same period in the prior year, the company posted $2.63 EPS. The company’s revenue was up 8.8% compared to the same quarter last year. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. As a group, equities analysts forecast that Waters Corporation will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.